Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

H. A.F. Stessman, A. Mansoor, F. Zhan, S. Janz, M. A. Linden, L. B. Baughn, B. Van Ness

Research output: Contribution to journalArticlepeer-review

42 Scopus citations
Original languageEnglish (US)
Pages (from-to)2075-2077
Number of pages3
Issue number10
StatePublished - Oct 2013

Bibliographical note

Funding Information:
BVN receives research support from Millennium Pharmaceuticals Inc., Cambridge, MA. The other authors declare no conflict of interest.

Cite this